Table 2.

The number of deaths in each group and the number of major adverse events

Mortality within 30 days						LVOT obstruction			Stroke			Vascular complication
All-cause mortality			Cardiovascular
ViV	ViR	ViMAC	ViV	ViR	ViMAC	ViV	ViR	ViMAC	ViV	ViR	ViMAC	ViV	ViR	ViMAC
3	0	2	–	–	–	3	3	2	–	–	–	–	–	–
20	14	20	–	–	–	7	7	23	7	0	2	5	5	4
9/172	5/73	–	5/172	5/73	–	0/172	4/73	–	3/95	1/47	–	16/172	0/73	–
–	0	6	–	0	4	–	–	4	–	–	3	–	0	2
47/584	12/104	20	28/584	7/104	–	5	6	10	7	0	4	20	6	–
56	19	–	–	–	–	–	–	–	12	1	–	49	4	–

Acute kidney injury			Postprocedural Mitral Regurgitation
			Trace/none			1 (+)			2 (+) or greater
ViV	ViR	ViMAC	ViV	ViR	ViMAC	ViV	ViR	ViMAC	ViV	ViR	ViMAC
–	–	–	–	–	–	–	–	–	–	–	–
14	13	7	–	–	–	–	–	–	–	–	–
7/172	4/73	–	107/145	40/67	–	30/145	19/67	–	8/145	8/67	–
–	0	1	–	–	–	–	–	–	–	–	–
–	–	–	557	63	55	93	44	36	8	3	2
75	29	–	660	113	–	171	73	–	26	36	–